Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | NSD2 | O96028 | 1/20 | 0.54 |
| ▸ | CASP6 | P55212 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALPL | P05186 | 2/20 | 0.54 |
| ▸ | ALPG | P10696 | 2/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | MMP14 | P50281 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31011001 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL29376206 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL30688251 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL1507672 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| Trimethylammonium SCHEMBL7090073 | 0.96 | MAPT (0.58) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL10087015 | 0.86 | THRB (0.59) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL16063029 | 0.86 | THRB (0.59) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL1486044 | 0.85 | L3MBTL1 (0.58) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL10087090 | 0.85 | KMT2A (0.46) | MAPTL3MBTL1NPC1MAPK1KDM4E | |
| SCHEMBL5363094 | 0.85 | L3MBTL1 (0.58) | MAPTL3MBTL1NPC1MAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210229364-A1 | STEREOLITHOGRAPHY WITH MICRON SCALE CONTROL OF PROPERTIES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2021-07-29 | — | — | US | claimed |
| US-10961342-B2 | Resin formulation and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-03-30 | — | — | US | claimed |
| US-20200087443-A1 | A Resin Formulation and Uses Thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-03-19 | — | — | US | claimed |
| WO-2018080397-A1 | A RESIN FORMULATION AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-05-03 | — | — | WO | claimed |
| US-12623408-B2 | Stereolithography with micron scale control of properties | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4536001-B1 | AGROCHEMICAL FORMULATIONS COMPRISING CRYSTALLINE FORM A OF 4-[(6-CHLORO-3-PYRIDYLMETHYL)(2,2-DIFLUOROETHYL)AMINO]FURAN-2(5H)-ONE | BAYER AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20250295791-A1 | COLLAGEN-CONTAINING CURABLE FORMULATIONS | COLLPLANT LTD. (IL) | 2025-09-25 | — | — | US | disclosed |
| EP-4422707-A1 | COLLAGEN-CONTAINING CURABLE FORMULATIONS | CollPlant Ltd. (IL) | 2024-09-04 | — | — | EP | disclosed |
| EP-4295683-A1 | AGROCHEMICAL FORMULATIONS COMPRISING CRYSTALLINE FORM A OF 4-[(6-CHLORO-3-PYRIDYLMETHYL)(2,2-DIFLUOROETHYL)AMINO]FURAN-2(5H)-ONE | Bayer Aktiengesellschaft (DE) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023237444-A1 | AGROCHEMICAL FORMULATIONS COMPRISING CRYSTALLINE FORM A OF 4-[(6-CHLORO-3-PYRIDYLMETHYL)(2,2-DIFLUOROETHYL)AMINO]FURAN-2(5H)-ONE | BAYER AKTIENGESELLSCHAFT (DE) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023073711-A1 | COLLAGEN-CONTAINING CURABLE FORMULATIONS | COLLPLANT LTD. (IL) | 2023-05-04 | — | — | WO | disclosed |
| US-20210229364-A1 | STEREOLITHOGRAPHY WITH MICRON SCALE CONTROL OF PROPERTIES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2021-07-29 | — | — | US | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| US-H227-H | Colored smoke-producing composition | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-03-03 | — | — | US | disclosed |
| US-4189475-A | MALTHION AND O,O-DIMETHYL S-(4-AZA-6-CHLORO-2-OXO-BENZOXAZOL-3-YL)-METHYL THIOPHOSPHATE | AIRWICK INDUSTRIES INC. (US) | 1980-02-19 | — | — | US | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3966900-A | INSECTICIDES | AIRWICK INDUSTRIES, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295791-A1 | COLLAGEN-CONTAINING CURABLE FORMULATIONS | COL1A1, COL14A1, COL2A1 | MAPT 155/4885L3MBTL1 2355/4885NPC1 4802/4885 |
| US-12623408-B2 | Stereolithography with micron scale control of properties | VCL, HTR3D, PIEZO1 | MAPT 478/4885L3MBTL1 1585/4885NPC1 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.